We further compared pretreatment ctDNA parameters, including the ctDNA concentration, mVAF, maximum VAF and TMB detected, between patients grouped by different clinical factors including Lauren classification, tumor site, and MSI/PD-L1/EBV status. The gene discussed is CD274; the disease is neoplasm.